Korro Bio, Inc.KRRONASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank50
5Y CAGR-16.3%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-16.3%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$649000.00-
2024$0.00-
2023$0.00-
2022$0.00-100.0%
2021$3.84M+143.1%
2020$1.58M-90.6%
2019$16.81M+2470.8%
2018$654000.00+23.2%
2017$531000.00-